Results 281 to 290 of about 490,947 (358)
Proteomic method identifies proteins nitrated in vivo during inflammatory challenge
Kulwant S. Aulak+6 more
openalex +1 more source
Immunomodulatory metal‐phenolic microcapsules (mMPMs) is developed in this study that leverages dopamine‐modified hyaluronic acid and FeIII assemble on mannose‐glycated bovine serum albumin microbubbles. mMPMs effectively promote macrophage internalization and M1 polarization, enhancing pro‐inflammatory responses.
Xin Tan+9 more
wiley +1 more source
Advances in multi-omics studies of microvascular invasion in hepatocellular carcinoma. [PDF]
Wang L+7 more
europepmc +1 more source
Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration
This work presents a creative pipeline for developing MDM2‐targeting PROTACs (MDM2‐PROTACs) for application in bone regeneration. The developed PROTACs (CL144 and CL174) are validated for their degradation efficiency and osteogenic effects in human BMSCs.
Sol Jeong+17 more
wiley +1 more source
Algorithms and tools for data-driven omics integration to achieve multilayer biological insights: a narrative review. [PDF]
Morabito A+4 more
europepmc +1 more source
This study investigates the integrated diagnostic and therapeutic strategy utilizing 89Zr/131I‐labeled tinurilimab for the management of malignant lung nodules, with a particular focus on lung adenocarcinoma (LUAD). CEACAM6, which is highly expressed in most LUAD patients, activates the Src/FAK signaling pathway, thereby promoting cell proliferation ...
Chongyang Chen+8 more
wiley +1 more source
Salivary Proteome Insights: Evaluation of Saliva Preparation Methods in Mucopolysaccharidoses Research. [PDF]
Soporan MA+6 more
europepmc +1 more source
A mini-review: Proteomic analysis, a post-genomic approach
Jean-François Chich
openalex +1 more source
Nuclear envelope proteomics: Novel integral membrane proteins of the inner nuclear membrane
Mathias Dreger+4 more
openalex +1 more source
Aided by FABP5, abnormally elevated asprosin in hepatocytes enters the nucleus, targets and inhibits PPARα binding to the CPT1A promoter, thereby suppressing FAO. Circulating asprosin exacerbates insulin resistance, collectively driving MASLD progression.
Yuan‐Yuan Yu+13 more
wiley +1 more source